Ukraine takes measures to solve problem of drug shortages

12 September 2014

Ukraine is experiencing a shortage of pharmaceutical products, as the country’s government does not have enough funds to make full-scale state procurements of drugs.

According to an official spokesperson for the Ukrainian Ministry of Public Health, there is currently a shortage of vital drugs in the country including insulin, chemotherapy drugs, analgesic and vaccines. The situation is aggravated by the fact that for the last several months prices for imported drugs have increased by three times, while local producers are currently unable to meet local needs in drugs.

In order to make drugs more affordable for local population, the Ukranian government has recently reduced the rate of value-added tax (VAT) for some type of drugs from 20% to 7%. At the same time Petro Poroshenko, President of the country, signed a decree several days ago, which allowed drug imports to Ukraine from the European Union and the USA without mandatory registration.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical